iGan Partners and Genesys Capital

iGan Partners and Genesys Capital in Flosonics Medical’s US$14 million financing round


iGan Partners and Genesys Capital


US$14 million


Emerging and High Growth Companies

Date Closed

February 2021

Lead Office



On February 2, 2021, Flosonics Medical announced the close of a US$14 million funding round which included participation from existing investors iGan Partners and Genesys Capital. Financing proceeds will be used for commercial launch in North America and new product development.

iGan Partners is a Toronto-based venture capital and private equity firm that invests in emerging tech companies.

Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology.

Flosonics Medical is a venture-backed medical device company headquartered in Sudbury, Ontario. Flosonics Medical is focused on the intersection of wearable sensors, ultrasound, and connected devices.

Osler, Hoskin & Harcourt LLP advised iGan Partners and Genesys Capital with a team consisting of André Perey, Michael Grantmyre, Jeremy Lin and Scott Lin (Emerging and High Growth Companies).